2 completed, 2 recruiting. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Bone Sarcomas: new trials by email Literature Review of Bone Sarcomas trials Research Report on Bone Sarcomas
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2 Trial of Zanzalintinib in Advanced/Metastatic Bone Sarcomas (ZAMBONE) Zanzalintinib - Bone Sarcomas | Phase 2 | Recruiting | M.D. Anderson Cancer Center | 70 | 2025-12-05 | 2026-09-25 |
| Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas data collection - Bone Sarcomas, Financial Toxicity | Recruiting | M.D. Anderson Cancer Center | 100 | 2025-09-02 | 2026-09-11 | |
| RAD001 in Advanced Sarcoma RAD001 - Soft Tissue Sarcomas, Bone Sarcomas | Phase 2 | Completed | Asan Medical Center | 41 | 2010-04-01 | 2013-04-12 |
| Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. PSMA/PRAME - Ovarian, Melanoma | Phase 1 | Completed | Mannkind Corporation | 12 | 2007-02-01 | 2010-08-03 |
Bone Neoplasms (4) · Sarcoma (2) · Anus Neoplasms (1) · Biliary Tract Neoplasms (1) · Breast Neoplasms (1) · Carcinoma, Neuroendocrine (1) · Endometrial Neoplasms (1) · Esophageal Neoplasms (1) · Financial Stress (1) · Gallbladder Neoplasms (1) · Liver Neoplasms (1) · Melanoma (1) · Mesothelioma (1) · Pancreatic Neoplasms (1) · Small Cell Lung Carcinoma (1)
Bone Diseases (4) · Musculoskeletal Diseases (4) · Neoplasms (4) · Neoplasms by Site (4) · Neoplasms by Histologic Type (2) · Neoplasms, Connective and Soft Tissue (2) · Adenocarcinoma (1) · Adenoma (1) · Anus Diseases (1) · Behavior (1) · Behavioral Symptoms (1) · Biliary Tract Diseases (1) · Breast Diseases (1) · Bronchial Neoplasms (1) · Carcinoma (1)
Data Collection (1) · Everolimus (1)
M.D. Anderson Cancer Center (2) · Asan Medical Center (1) · Mannkind Corporation (1)
United States (3) · South Korea (1)
Jin-Hee Ahn, MD, PhD (1) · John Livingston, MD (1) · Shalin S Patel, MD (1)